97065 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants for hormones G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
TREATMENT OF EPILEPSY
#2G-PROTEIN-GATED-K+ CHANNEL-MEDIATED ENHANCEMENTS IN LIGHT SENSITIVITY IN ROD-CONE DYSTROPHY (RCD)
#3PREVENTING AND SUPPRESSING PROGRESSION OF, RETINAL DISEASE, IMPROVING VISUAL COGNITIVE BEHAVIORAL FUNCTION, AND STRENGTHENING VISUAL FUNCTION
#4CANCER ANTIGEN TARGETS AND USES THEREOF
#5IG-LIKE FUSION PROTEINS FOR TREATING GRAVES DISEASE
#6MELANOPSIN VARIANTS FOR VISION RESTORATION
#7METHOD FOR ANALYZING G-PROTEIN CONJUGATED RECEPTOR
#8WATER-SOLUBLE TRANS-MEMBRANE PROTEINS AND METHODS FOR THE PREPARATION AND USE THEREOF
#9CELLS DERIVED FROM POLYPEDILUM VANDERPLANKI AND ODOR SENSOR EQUIPPED THEREWITH
#10METHOD OF TREATING MELANOCORTIN-4 RECEPTOR PATHWAY-ASSOCIATED DISORDERS
#11SYSTEMS AND METHODS FOR GENETIC MODULATION TO TREAT OCULAR DISEASES
#12COMPOSITION FOR TREATING OR PREVENTING DISEASES, DISORDERS, OR CONDITIONS ASSOCIATED WITH ENDOPLASMIC RETICULUM STRESS OR ALL-TRANS-RETINAL, PROTECTING RETINAL THICKNESS, OR SUPPRESSING REDUCTION IN RETINAL THICKNESS OR PROGRESS OF REDUCTION IN RETINAL THICKNESS
#13MELANOCORTIN 1 RECEPTOR LIGANDS AND METHODS OF USE
#14RECOMBINANT PROTEIN OF GPER
#1520-HETE RECEPTOR (GPR75) ANTAGONISTS AND METHODS OF USE
#16Screening Assays, Modulators and Modulation of Activation of Receptor for Advanced Glycation End-Products (RAGE)
#17ULTRA LIGHT-SENSITIVE NEUROPSIN-BASED OPTOGENETIC TOOL FOR ACTIVATING G q-COUPLED SIGNALING AND/OR ACTIVATING CELLS
#18RECOMBINANT THYROID-STIMULATING HORMONE RECEPTOR PROTEIN, PREPARATION METHOD AND APPLICATION THEREOF
#19Novel Animal Model for Autoimmune Disease
#20PHARMACOLOGICAL AND/OR GENETIC ACTIVATOR FOR USE IN PRESERVING AND REGENERATING MUSCLE STRUCTURE AND FUNCTION BY BLOCKING SENESCENCE
#21ECTOPICALLY EXPRESSED TRANSCRIPTION FACTORS AND USES THEREOF
#22AGENT FOR RESTORING VISUAL FUNCTION OR AGENT FOR PREVENTING DETERIORATION IN VISUAL FUNCTION
#23METHOD OF TREATING MELANOCORTIN-4 RECEPTOR-ASSOCIATED DISORDERS IN HETEROZYGOUS CARRIERS
#24COMPOSITIONS AND METHODS FOR AMELIORATING ANTERODORSAL THALAMUS HYPEREXCITABILITY
#25FLUORESCENT BIOSENSORS AND METHODS OF USE FOR DETECTING CELL SIGNALING EVENTS
#26Optimized Synthetic Consensus Immunogenic Compositions Targeting the Follicle Stimulating Hormone Receptor (FSHR)
#27PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF
#28SYSTEM AND METHOD FOR HOMOGENOUS GPCR PHOSPHORYLATION AND IDENTIFICATION OF BETA-2 ADRENERGIC RECEPTOR POSITIVE ALLOSTERIC MODULATORS
#29Artificial Transmembrane Proteins for Detecting Intracellular or Intravesicular Biomolecular Interactions
#30G PROTEIN PEPTIDOMIMETICS
#31MUTANT G-PROTEIN COUPLED RECEPTORS AND METHODS FOR SELECTING THEM
#32GLYCOPROTEIN HORMONE RECEPTOR MUTATIONS
#3320-HETE RECEPTOR (GPR75) ANTAGONISTS AND METHODS OF USE
#34GPCR SCREENING METHOD TO IDENTIFY NON-HALLUCINOGENIC COMPOUNDS
#35GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC GLP1R
#36Bifunctional Proteins Combining Checkpoint Blockade for Targeted Therapy
#37Somatostatin Receptor
#38NOVEL RHODOPSIN MUTANTS
#39TRANSDUCED T CELLS EXPRESSING HUMAN SSTR2 AND APPLICATION THEREOF
#40ULTRA-SENSITIVE STEP-FUNCTION OPSIN FOR MINIMALLY INVASIVE OPTOGENETIC STIMULATION
#41COMPOSITIONS AND METHODS FOR TREATING G PROTEIN COUPLED RECEPTOR MEDIATED CONDITIONS
#42METHOD FOR GENERATING VARIANTS OF A PROTEIN
#43Melanocortin 1 receptor ligands and methods of use
#44Protease-controlled Secretion and Display of Intercellular Signals
#45RODENT MODEL OF MOOD DISORDERS
#46LASSO PEPTIDES FOR TREATMENT OF CANCER
#47TOOLS AND METHODS FOR EXPRESSION OF MEMBRANE PROTEINS
#48OPTOGENETIC COMPOSITIONS COMPRISING A CBh PROMOTER SEQUENCE AND METHODS FOR USE
#49FC-FUSION PROTEIN DERIVATIVES WITH HIGH DUAL HIV ANTIVIRAL AND IMMUNOMODULATORY ACTIVITY
#50METHODS OF TREATING CANCER PATIENTS WITH RAS NODE OR RTK TARGETED THERAPEUTIC AGENTS
#51REAL-TIME G-PROTEIN COUPLED RECEPTOR (GPCR) LINKED BIOLUMINESCENT SENSING OF BIOLOGICAL TARGETS AND PROCESSES
#52Compositions and Uses for Engineered Therapeutic Microbes and Associated Receptors
#53COMPOSITIONS COMPRISING BOVINE ADRENAL MEDULLA 8-22 (BAM8-22) PEPTIDE ANALOGS AND METHODS OF USE
#54Screening Methods and Assays for Use with Transmembrane Proteins, in Particular with GPCRs
#55SYSTEMS AND METHODS FOR MEASURING CELL SIGNALING PROTEIN ACTIVITY
#56METHOD OF TREATING MELANOCORTIN-4 RECEPTOR PATHWAY-ASSOCIATED DISORDERS
#57SCREENING METHODS USING CANINE T2R RECEPTORS AND PET FOOD PRODUCTS AND COMPOSITIONS IDENTIFIED USING THE SAME
#58BETA-ARRESTIN MUTANTS
#59Protein binding domains stabilizing functional conformational states of GPCRS and uses thereof
#60CANCER ANTIGEN TARGETS AND USES THEREOF
#61Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages
#62Short cyclic peptides for the treatment of Graves' disease
#63PREVENTING, AND SUPPRESSING PROGRESSION OF, RETINAL DISEASE, IMPROVING VISUAL COGNITIVE BEHAVIORAL FUNCTION, AND STRENGTHENING VISUAL FUNCTION
#64MODIFIED CHANNEL RHODOPSIN
#65TREATMENT OF RETINAL DEGENERATION USING GENE THERAPY
#66Anti-bril antibody
#67I DOMAIN CHIMERIC ANTIGEN RECEPTOR SPECIFIC TO ICAM-1
#68METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING POLYCYSTIC OVARY SYNDROME
#69COMPOSITIONS AND METHODS FOR TREATING PAIN, INFLAMMATION, INFECTION, MALARIA, AND SEPSIS
#70Synthetic odorant receptors
#71G protein-coupled receptor (GPCR) ligand assay
#72Method of treating melanocortin-4 receptor pathway-associated disorders
#73APJ antibody, fusion protein thereof with Elabela, and pharmaceutical compositions and use thereofus01
#74METHODS FOR SCREENING FOR BINDING PARTNERS OF G-PROTEIN COUPLED RECEPTORS
#75G-PROTEIN-COUPLED RECEPTOR INTERNAL SENSORS
#76COMPOSITIONS AND METHOD FOR REDUCING SEIZURES
#77Protease-activated receptor-2 modulators
#78Mutant G-protein coupled receptors and methods for selecting them
#79Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers
#80BLOOD-FREE DIET FOR REARING MALARIA MOSQUITO VECTORS
#81FUSION POLYPEPTIDE
#82MRGPRX2/MRGPRB2 EXPRESSING CELL BASED ASSAY TO DETECT PSEUDO-ALLERGIC DRUG REACTIONS AND TO IDENTIFY BLOCKERS TO PREVENT THE ADVERSE REACTIONS
#83Methods of Detecting Alloantibodies Using HLA and Non-HLA Antigens
#84METHOD OF TREATING A METABOLIC DISORDER OF THE LIVER
#85Force sensor cleavage domain containing chimeric polypeptides and methods of use thereof
#86Diagnosis and therapy of multiple sclerosis
#87TREATMENT OF EYE DISEASE
#88Bifunctional proteins combining checkpoint blockade for targeted therapy
#89SCREENING METHODS USING CANINE T2R RECEPTORS AND PET FOOD PRODUCTS AND COMPOSITIONS IDENTIFIED USING THE SAME
#90Rodent model of mood disorders
#91SENSITIVE DETECTION OF G-PROTEIN COUPLED RECEPTOR-ASSOCIATED SORTING PROTEIN 1 (GASP-1), GASP-1 MICROVESICLES, AND GASP-1 EXOSOMES
#92Integral membrane protein display on poxvirus extracellular enveloped virions
#93Screening assays, modulators and modulation of activation of Receptor for Advanced Glycation End-products (RAGE)
#94Cancer antigen targets and uses thereof
#95Transduced T cells expressing human SSTR2 and application thereof
#96WATER-SOLUBLE TRANS-MEMBRANE PROTEINS AND METHODS FOR THE PREPARATION AND USE THEREOF
#97Method for treating a chronic itch condition by administering small molecule MrgprX4 antagonists
#98Compositions comprising D-amino acid peptides and methods of production and use thereof for inhibiting autoantibodies
#99Methods of using an antibody to stabilize and analyze a BRIL fusion protein
#100BIOSENSORS FOR MONITORING BIOMOLECULE LOCALIZATION AND TRAFFICKING IN CELLS
#101Composition comprising a lyophilized detergent-solubilized protein
#102Cyclic peptides for the treatment of Graves' disease
#103Specific GNAI:GIV interaction screening assays, methods and compositions
#104Method of identifying musk compounds
#10520-HETE receptor (GPR75) antagonists and methods of use
#106Protein binding domains stabilizing functional conformational states of GPCRS and uses thereof
#107I domain chimeric antigen receptor specific to ICAM-1
#108Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers
#109CHIMERIC ANTIGEN RECEPTORS AND COMPOSITIONS AND METHODS OF USE THEREOF
#110Melanocortin 1 receptor ligands and methods of use
#111PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF
#112Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof
#113PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF
#114PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF
#115PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF
#116Vreceptor antagonist for use in the treatment of patients having an elevated AVP level and/or an elevated copeptin level
#117Opioid receptor binding agents and uses thereof
#118Membrane span-kinase fusion protein and the uses thereof
#119Method of Identifying Transmembrane Protein-interacting Compounds
#120Modulators of melanocortin receptors
#121CELL EXPRESSING CAR AND GPCR
#122TREATMENT OF EYE DISEASE
#123Integral membrane protein display on poxvirus extracellular enveloped virions
#124Peptides derived from the propeptide NTSR3 and their use in the treatment of depression
#125MUTANT G-PROTEIN COUPLED RECEPTORS AND METHODS FOR SELECTING THEM
#126System and method for homogenous GPCR phosphorylation and identification of beta-2 adrenergic receptor positive allosteric modulators
#127Fusion protein for treating intestinal diseases
#128Mesitylene-cored amphiphiles and uses thereof
#129Methods of using T1R hetero-oligomeric taste receptors to screen for compounds which modulate sweet or umami taste signaling
#130Agent for restoring visual function or agent for preventing deterioration in visual function
#131Nucleic acid encoding optimized immunogenic peptide that targets follicle stimulating hormone receptor
#132Genetically encoded calcium indicators and methods of use
#133Method for increasing cardiac inflow by administering a compound that binds RXFP1
#134COMPOSITIONS AND METHODS FOR OLIGODENDROCYTE DEVELOPMENT
#135Integral membrane protein display on poxvirus extracellular enveloped virions
#136Stable proteins
#137Compositions and their use for controlling the nervous system in vivo
#138METHODS FOR SCREENING FOR BINDING PARTNERS OF G-PROTEIN COUPLED RECEPTORS
#139TIR taste receptors and genes encoding same
#140Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof
#141Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof
#142PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF
#143Targeting of melanocytes for delivering therapeutic or diagnostic agents using protein nanocages
#144NUCLEIC ACIDS ENCODING A G-PROTEIN COUPLED RECEPTOR INVOLVED IN SENSORY TRANSDUCTION
#145SCREENING METHODS USING CANINE T2R RECEPTORS AND PET FOOD PRODUCTS AND COMPOSITIONS IDENTIFIED USING THE SAME
#146TREATMENT OF EYE DISEASE
#147Stabilized liquid formulations containing receptors
#148Cancer antigen targets and uses thereof
#149Transformed cell lines expressing non-endogenous cell-surface selective guanosine-responsive G-protein coupled receptors
#150Peptides
#151Compositions and methods for treating central nervous system (CNS) disorders and mood disorders
#152Kinin-based theranostic probes for solid cancers and uses thereof
#153Method of treating melanocortin-4 receptor pathway-associated disorders
#154Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N
#155Compositions Comprising D-Amino Acid Peptides and Methods of Production and Use Thereof for Inhibiting Autoantibodies
#156Detergent-protein composition comprising lyophilized detergent-solubilized protein
#157Method of Identifying Transmembrane Protein-interacting Compounds
#158Thyroid stimulating hormone receptor peptides and uses thereof
#159Tools and methods for expression of membrane proteins
#160Detection of autoantibodies against the TSH receptor
#161Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers
#162Mobilizing agents and uses therefor
#163PAR1 and PAR2 c-tail peptides and peptide mimetics
#164METHOD FOR IDENTIFYING COMPOUNDS THAT MODULATE A T2R TASTE RECEPTOR
#165Methods and compositions for restoration of cone function in BCM
#166Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof
#167COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER
#168Compositions and Methods for Diagnosing and Treating Cancer
#169T1R taste receptors and genes encoding same
#170MUTANT G-PROTEIN COUPLED RECEPTORS AND METHODS FOR SELECTING THEM
#171Compositions and method for reducing seizures
#172Backbone-cyclized peptidomimetics with GLP-1R modulating activity
#173Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof
#174Methods for labeling and manipulating a cellular circuit
#175Transduced T cells expressing human SSTR2 and application thereof
#176I domain chimeric antigen receptor specific to ICAM-1
#177V1B RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF PATIENTS HAVING AN ELEVATED AVP LEVEL AND/OR AN ELEVATED COPEPTIN LEVEL
#178WATER-SOLUBLE MEMBRANE PROTEINS AND METHODS FOR THE PREPARATION AND USE THEREOF
#179Method of Identifying Transmembrane Protein-interacting Compounds
#180Renilla based biosensors for monitoring biomolecule localization and trafficking in cells
#181T1R taste receptors and genes encoding same
#182Compositions and Methods for Treating and Diagnosing Cancer
#183Pharmaceutical composition for treating bone diseases which comprises protein comprising Frizzled 1, Frizzled 2 or Frizzled 7 extracellular cysteine-rich domain
#184Biosensor based on Gβγ-interacting proteins to monitor G-protein activation
#185Nucleic acid sequence encoding a fusion protein
#186Method of expressing a G-protein coupled receptor protein
#187Methods of using TIR hetero-oligomeric receptors for screening compounds that modulate sweet or umami taste
#188NOVEL FUSION PARTNERS FOR THE PURPOSE OF CRYSTALLIZING G-PROTEIN COUPLED RECEPTORS
#189Melanocortin 1 receptor ligands and methods of use
#190MrgprX2/MrgprB2 expressing cell based assay to detect pseudo-allergic drug reactions and to identify blockers to prevent the adverse reactions
#191Glycoprotein hormone receptor mutations
#192Compositions And Methods For Treating Tumors And Immune Based Inflammatory Diseases
#193Polypeptides derived from calcitonin receptors and methods of use
#194G protein coupled receptor 85 and SREB3 knockout mice and uses thereof
#195Opioid receptor binding agents and uses thereof
#196Compositions and methods for increasing the expression and signalling of proteins on cell surfaces
#197Protein binding domains stabilizing functional conformational states of GPCRS and uses thereof
#198MUTANT G-PROTEIN COUPLED RECEPTOR PROTEINS AND METHODS FOR PRODUCING THEM
#199Modulation of cellular stress using a B-cell oxidative and/or endoplasmic reticulum stress inhibitor and a targeting agent
#200Protease-activated receptor-2 modulators
#201Methods of Detecting Alloantibodies Using HLA and Non-HLA Antigens
#202CELL LINE, SYSTEM AND METHOD FOR OPTICAL CONTROL OF SECONDARY MESSENGERS
#203PAR-1 based therapeutic conjugates and uses thereof
#204Enhanced AAV-mediated gene transfer for retinal therapies
#205Methods for the treatment of depression and anxiety
#206Methods for the treatment of central nervous system (CNS) disorders and mood disorders
#207Methods of treating hedgehog-related diseases with an anti-LGR5 antibody
#208Diagnosis and therapy of multiple sclerosis
#209Capsid-mutated rAAV vectors and methods of use
#210Treatment of retinal degeneration using gene therapy
#211Compositions and methods for treating acute and chronic pain by local antagonism of CGRP receptors, or combination with sodium channel inhibition or with anti-inflammatory agents
#212Methods and monitoring of treatment with a WNT pathway inhibitor
#213TRANSGENIC MOUSE MODELS FOR MC4R
#214Fusion tags for protein expression
#215Methods for screening for binding partners of G-protein coupled receptors
#216CELL LINES AND METHODS FOR MAKING AND USING THEM
#217Compositions Comprising D-Amino Acid Peptides and Methods of Production and Use Thereof for Inhibiting Autoantibodies
#218Methods of treating cancer by administering a soluble receptor comprising a human Fc domain and the Fri domain from human frizzled receptor
#219Peptides
#220Melanotropin ligands for skin care
#221Method for determining mutateable ligand-GPCR binding at single amino acid resolution and pairs of mutated ligand and GPCR
#222Growth hormone secretagogue receptor based protein
#223HYBRID PROTEIN THAT CONVERTS ARACHIDONIC ACID INTO PROSTACYCLIN
#224Stabilized liquid formulations containing receptors
#225INDUCTION OF ANTIGEN-SPECIFIC TOLERANCE
#226MUTANT G-PROTEIN COUPLED RECEPTORS AND METHODS FOR SELECTING THEM
#227Chimeric polypeptides comprising G protein-coupled receptors and VHH antibodies
#228Water-soluble trans-membrane proteins and methods for the preparation and use thereof
#229TRH binding site in human CNS
#230Method of screening compounds for the treatment of diabetes
#231Compositions and methods for treating and diagnosing cancer
#232T1R taste receptors and genes encoding same
#233T1R taste receptors and genes encoding same
#234Sweet taste receptor chimeric proteins and use thereof
#235CRYSTAL STRUCTURE
#236Method for identifying compounds that modulate a T2R taste receptor
#237Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof
#238MELANOCORTIN RECEPTOR MUTANT MOUSE AND USES THEREOF
#239VECTORS FOR DELIVERY OF LIGHT SENSITIVE PROTEINS AND METHODS OF USE
#240Cell line, system and method for optical control of secondary messengers
#241Method and composition for crystallizing G protein-coupled receptors
#242Nanodisc clathrates and uses thereof
#243GPCR with improved cell surface expression
#244GPR88 MINI-PROMOTERS
#245Fusion expression of G-protein coupled receptor
#246Compositions and methods for treating and diagnosing cancer
#247Marker peptide for determining risk of developing metabolic syndrome, and use thereof
#248Assay for assessing conformational stability of membrane protein
#249MUTANT DOUBLE CYCLIZED RECEPTOR PEPTIDES INHIBITING BETA1-ADRENOCEPTOR ANTIBODIES
#250Mutations of the GPR179 Gene in Congenital Stationary Night Blindness
#251Methods of screening T1R hetero-oligomeric taste receptors for sweet taste modulators
#252Membrane span-kinase fusion protein and the uses thereof
#253Tools and methods for expression of membrane proteins
#254Methods of using the FRI domain of human frizzled receptor for inhibiting Wnt signaling in a tumor or tumor cell
#255Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers
#256CHOLECYSTOKININ B RECEPTOR (CCKBR) MINI-PROMOTERS
#257Stable proteins
#258Compositions and Methods for Increasing Stress Resilience
#259GPCR fusion protein containing an N-terminal autonomously folding stable domain, and crystals of the same
#260Inhibitors of metastasis, methods of generating such inhibitors and their therapeutic applications
#261CLONED GLUCAGON-LIKE PEPTIDE-2 RECEPTORS
#262Gpr177 as target and marker in tumors
#263Method and composition for crystallizing G protein-coupled receptors
#264Methods for determining binding capability of target ligands with G protein-coupled receptors using translocation through nanochannels
#265Light-sensitive chimeric GPCR protein
#266Endogenous and Non-Endogenous Versions of Human G Protein-Coupled Receptors
#267GPCR comprising an IC2 insertion
#268Compositions and methods for treating and diagnosing cancer
#269Melanocortin 1 receptor ligands and methods of use
#270Crystal structure
#271G-protein coupled receptor polypeptides involved in sensory transduction
#272Structural model of G protein-coupled receptor and method for designing ligand capable of binding to G protein-coupled receptor using the structural model
#273E518A/K mutant smoothened and methods of using the same
#274Polypeptides derived from calcitonin receptors and methods of use
#275T1R taste receptors and genes encoding same
#276Compositions and methods for treating and diagnosing cancer
#277PAR1 and PAR2 c-tail peptides and peptide mimetics
#278Endogenous and Non-Endogenous Versions of Human G Protein-Coupled Receptors
#279Peptides having binding affinity to an antibody which recognizes an epitope on an α1 loop 2 or β2 loop 1 of an adrenoreceptor
#280Human frizzled (FZD) receptor polypeptides and methods of use thereof for treating cancer and inhibiting growth of tumor cells
#281Pharmaceutical composition for treating bone diseases which comprises protein comprising Frizzled1, Frizzled2 or Frizzled7 extracellular cysteine-rich domain
#282CRYSTALS OF MEMBRANE PROTEINS
#283Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof
#284Growth hormone secretatogue receptor antagonists and uses thereof
#285G-PROTEIN-CONJUGATED RECEPTOR HAVING ALTERED LIGAND AFFINITY, AND USE THEREOF
#286Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
#287Method of identifying transmembrane protein-interacting compounds
#288Method for producing cAMP using chimeric olfactory receptor
#289Detection of human T1R expressing cells
#290Methods of identifying modulators of GPR17
#291Chimeric Polypeptides Useful in Proximal and Dynamic High-Throughput Screening Methods
#292Modulation of glucagon receptor expression
#293NOVEL FUSION PARTNERS FOR THE PURPOSE OF CRYSTALLIZING G-PROTEIN COUPLED RECEPTORS
#294T1R taste receptors and genes encoding same
#295MUTANT G-PROTEIN COUPLED RECEPTORS AND METHODS FOR SELECTING THEM
#296GPCR fusion protein containing an N-terminal autonomously folding stable domain, and crystals of the same
#297CONSTRUCTS THAT ALLOW FOR DETECTION AND QUANTITATION OF MEMBRANE PROTEINS
#298GPCR comprising an IC2 insertion
#299Cholinergic/serotoninergic receptor and uses thereof
#300NOVEL THERAPEUTIC USES OF HUMAN FORMYL PEPTIDE RECEPTOR ANTAGONISTS